Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.43 USD | -0.86% | +11.94% | 0.00% |
Business Summary
Number of employees: 61
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Bladder-sparing Therapeutic
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +6.81% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +6.81% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Arthur Kuan
CEO | Chief Executive Officer | 34 | 17-11-29 |
Ambaw Bellete
PSD | President | 54 | 23-06-30 |
Vijay Kasturi
CTO | Chief Tech/Sci/R&D Officer | 57 | 23-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Graf
BRD | Director/Board Member | 52 | Nov. 19 |
Leonard Post
BRD | Director/Board Member | 72 | 18-10-21 |
Victor Tong
BRD | Director/Board Member | 41 | 23-06-30 |
James Mulé
BRD | Director/Board Member | 72 | 18-10-21 |
Arthur Kuan
CEO | Chief Executive Officer | 34 | 17-11-29 |
Hong Fang Song
BRD | Director/Board Member | 59 | 15-10-31 |
Brian Liu
BRD | Director/Board Member | 36 | 22-08-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 66,640,150 | 61,943,223 ( 92.95 %) | 0 | 92.95 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 2.16B | |
+54.05% | 58.71B | |
-2.02% | 41.31B | |
+40.01% | 39.2B | |
-10.22% | 27.4B | |
+13.42% | 26.55B | |
-21.60% | 18.98B | |
+2.89% | 12.51B | |
+22.40% | 11.94B | |
+27.49% | 12.08B |
- Stock Market
- Equities
- CGON Stock
- Company CG Oncology, Inc.